Aetna and Humana called off a $34 billion proposal to combine the two major health insurers after a federal judge, citing antitrust concerns, shot down the deal.
The announcement Tuesday comes several days after another federal judge rejected a tie-up between two other massive insurers. Blue Cross-Blue Shield carrier Anthem is attempting to buy Cigna for $48 billion. Anthem has vowed to appeal that decision.
Aetna, the nation’s third largest insurer, had announced its bid for Humana in 2015. The deal would have given Aetna the opportunity to significantly expand its presence in the fast-growing market for Medicare Advantage plans, privately run versions of the federal Medicare program for people who are over 65 or disabled.
But Aetna’s attempt to gobble up the nation’s fifth largest health insurer brought in the Department of Justice, which sued to block the deal last summer.
US District Judge John Bates wrote in the decision last month that neither new competition nor plans to shed some of the combined company’s businesses would be enough to ease antitrust concerns. Federal regulation would likely be “insufficient to prevent the merged firm from raising prices or reducing benefits,” Bates ruled.
Aetna Chairman and CEO Mark Bertolini said in a company release Tuesday that “the current environment makes it too challenging to continue pursuing the transaction.”
Humana is entitled to a $1 billion breakup fee, which would amount to about $630 million after taxes. The Louisville, Kentucky, insurer says it will announce its 2017 forecast and provide an update on its strategic plan after markets close Tuesday.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI